Goods & Services

(1) Antibiotics for veterinary use

Abstract

Provided herein are chewable oral formulations including pimobendan for use in mammals to treat cardiac disorders.

IPC Classes  ?

• A61K 31/501 - PyridazinesHydrogenated pyridazines not condensed and containing further heterocyclic rings
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
• A61K 9/50 - Microcapsules

Abstract

The present invention relates to a formulation and method for treating an ear infection, especially otomycosis and otitis externa, by administering a one-time only treatment comprising an antibiotic, antifungal, and an anti-inflammatory in a thick, otic carrier. In one embodiment, the formulation comprises a therapeutically effective amount of active ingredients including a marbofloxacin, terbinafine and/or clotrimazole and dexamethasone.

IPC Classes  ?

• A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
• A61D 7/00 - Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61K 31/4174 - Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
• A61K 31/5395 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
• A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids
• A61K 31/58 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
• A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body
• A61P 27/16 - Otologicals
• A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.

IPC Classes  ?

• A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Goods & Services

Antibiotics for veterinary use

Abstract

Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection.

IPC Classes  ?

• A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61K 31/497 - Non-condensed pyrazines containing further heterocyclic rings
• A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
• A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• A61K 47/28 - Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Goods & Services

(1) Bactericides; bactericides for use in dental products; bactericides for use in water additives, oral sprays, toothpastes, dental wipes, and dental chews.

Goods & Services

(1) Bactericides; bactericides for use in dental products; bactericides for use in water additives, oral sprays, toothpastes, dental wipes, and dental chews.

Goods & Services

(1) Bactericides; bactericides for use in dental products; bactericides for use in water additives, oral sprays, toothpastes, dental wipes, and dental chews.

Abstract

Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.

IPC Classes  ?

• A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/20 - Pills, lozenges or tablets
• A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine
• A61K 31/635 - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide having a heterocyclic ring, e.g. sulfadiazine
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
• A61P 25/04 - Centrally acting analgesics, e.g. opioids
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]

Goods & Services

Bactericides; bactericides sold as an ingredient of dental products in the nature of medicated toothpaste; bactericides sold as an ingredient of water additives, oral sprays, and dental wipes, all being medicated dental preparations for the control of dental plaque, tartar, and halitosis in pets Bactericides sold as an ingredient of dental chews being rawhide chews for dogs

Goods & Services

Bactericides; bactericides sold as an ingredient of dental products in the nature of medicated toothpaste; bactericides sold as an ingredient of water additives, oral sprays, and dental wipes, all being medicated dental preparations for the control of dental plaque, tartar, and halitosis in pets Bactericides sold as an ingredient of dental chews being rawhide chews for dogs

Goods & Services

Bactericides; bactericides sold as an ingredient of dental products in the nature of medicated toothpaste; bactericides sold as an ingredient of water additives, oral sprays, and dental wipes, all being medicated dental preparations for the control of dental plaque, tartar, and halitosis in pets Bactericides sold as an ingredient of dental chews being rawhide chews for dogs

Abstract

Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.

IPC Classes  ?

• A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Goods & Services

Veterinary anesthetic preparation for surgical and nonsurgical use; Nonnarcotic, nonbarbiturate, injectable anesthetic agent for dogs and cats for surgical and nonsurgical use

Goods & Services

Veterinary preparations in the nature of euthanasia solutions and injectable euthanasia solutions for use in animals

Goods & Services

Veterinary preparations in the nature of euthanasia solutions and injectable euthanasia solutions for use in animals

Goods & Services

Veterinary preparation for the treatment of otitis externa in animals, otic preparation for the treatment of bacterial, fungal, and yeast infections in animals

Goods & Services

Veterinary preparations for treatment of atopic dermatitis and allergic dermatitis; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunosuppressants for veterinary use

Goods & Services

(1) Veterinary preparations, namely ophthalmic preparations

Abstract

Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.

IPC Classes  ?

• A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Goods & Services

Anti-inflammatories

Goods & Services

veterinary preparations, namely, inhalant anesthetics

Goods & Services

veterinary preparations, namely, ophthalmic preparations

Goods & Services

veterinary preparations, namely, inhalant anesthetics

Abstract

Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.

IPC Classes  ?

• A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine
• A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• A61K 47/38 - CelluloseDerivatives thereof
• A61K 47/02 - Inorganic compounds
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61P 29/02 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Abstract

Provided herein are chewable oral formulations including pimobendan for use in mammals to treat cardiac disorders.

IPC Classes  ?

• A61K 31/501 - PyridazinesHydrogenated pyridazines not condensed and containing further heterocyclic rings
• A61K 9/50 - Microcapsules
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets

Abstract

The present invention relates to a formulation and method for treating an ear infection, especially otomycosis and otitis externa, by administering a one-time only treatment comprising an antibiotic, antifungal, and an anti-inflammatory in a thick, otic carrier. In one embodiment, the formulation comprises a therapeutically effective amount of active ingredients including a marbofloxacin, terbinafine and/or clotrimazole and dexamethasone.

IPC Classes  ?

• A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
• A61D 7/00 - Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61K 31/4174 - Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
• A61K 31/5395 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
• A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids
• A61K 31/58 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
• A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body
• A61P 27/16 - Otologicals
• A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection.

IPC Classes  ?

• A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61K 31/497 - Non-condensed pyrazines containing further heterocyclic rings
• A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
• A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• A61K 47/28 - Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Abstract

A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.

IPC Classes  ?

• A01N 43/22 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with one hetero atom rings with more than six members
• A01N 47/34 - Ureas or thioureas containing the groups N—CO—N or N—CS—N containing the groups , e.g. biuretThio-analogues thereofUrea-aldehyde condensation products
• A61K 31/17 - Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine
• A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/20 - Pills, lozenges or tablets
• A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate

Goods & Services

Veterinary preparations, namely, antibiotics

Abstract

Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.

IPC Classes  ?

• A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Abstract

Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.

IPC Classes  ?

• A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
• A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine
• A61K 31/635 - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide having a heterocyclic ring, e.g. sulfadiazine
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61P 25/04 - Centrally acting analgesics, e.g. opioids

Goods & Services

Tube applicator for topical veterinary product, namely, a tube applicator filled with antiparasitic preparations

Goods & Services

Veterinary preparations, namely, shampoos, spray conditioners and otic cleansers for the treatment of bacterial and fungal infections; medicated pre-moistened wipes for animals; dermatological preparations and otic preparations for animals.

Abstract

A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.

IPC Classes  ?

• A01N 43/22 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with one hetero atom rings with more than six members
• A01N 47/34 - Ureas or thioureas containing the groups N—CO—N or N—CS—N containing the groups , e.g. biuretThio-analogues thereofUrea-aldehyde condensation products
• A61K 31/17 - Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine
• A61K 9/20 - Pills, lozenges or tablets
• A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
• A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
• A61K 9/00 - Medicinal preparations characterised by special physical form

Goods & Services

(1) Veterinary preparations, namely, shampoos, spray conditioners and otic cleansers for the treatment of bacterial and fungal infections; medicated pre-moistened wipes for antifungal, antibacterial, whitening and degreasing of an animal's coat and skin; dermatological preparations and otic preparations for animals containing acetic acid and boric acid

Goods & Services

veterinary preparations, namely, shampoos, spray conditioners and otic cleansers for the treatment of bacterial and fungal infections; medicated pre-moistened wipes for animals; dermatological preparations and otic preparations for animals

Goods & Services

veterinary preparations, namely, shampoos, spray conditioners and otic cleansers for the treatment of bacterial and fungal infections; dermatological preparations and otic preparations for animals

Goods & Services

(1) Veterinary preparations, namely, medicated shampoos, sprays, mousses, and ear flushes for the treatment of bacterial and fungal infections; medicated anti-bacterial and anti-fungal pre-moistened wipes.

Goods & Services

(1) Oral hygiene and dental health products for pets, namely, dental wipes, water additives, oral sprays, toothpastes, chews and treats.

Goods & Services

oral and dental care products for veterinary use, namely, medicated dental wipes, water additives for oral and dental care, medicated oral sprays for oral and dental care, and medicated toothpastes oral hygiene and dental health products for pets, namely, edible chews and treats

Goods & Services

(1) Otic preparations for animals, namely ear cleansers

Goods & Services

(1) Dermatological preparations for animals for the treatment of itchy, dry or damaged coat and skin.

Goods & Services

(1) Otic preparations for animals, namely ear cleansers

Goods & Services

(1) Dietary and nutritional supplements for animals, namely, omega-3 and omega-6 supplements.

Goods & Services

(1) Dermatological preparations and otic preparations for animals for the treatment of bacterial skin conditions; Dermatological preparations and otic preparations for animals for the treatment of fungal skin conditions; Dermatological preparations and otic preparations for animals for the treatment of seborrheic skin conditions

Goods & Services

(1) Otic preparations for animals, namely ear cleansers

Goods & Services

(1) Medicated dermatological preparations for animals, namely, antibacterial, antiseborrheic, keratolytic and keratoplastic shampoos; and medicated dermatological preparations for animals, namely, shampoos for barrier repair, degreasing and follicular flushing.

Goods & Services

(1) Non-medicated dermatological preparations for animals for the treatment of dry or damaged coat and skin.

Goods & Services

(1) Dermatological preparations and otic preparations for animals, namely skin cleanser, ear flush, and spray conditioner

Goods & Services

(1) Dermatological preparations and otic preparations for animals, namely antifungal, antimicrobial, and antibacterial medications

Goods & Services

(1) Dermatological preparations for animals for the treatment of fungal infections, yeast infections, and parasitic skin infections

Goods & Services

(1) Dermatological preparations and otic preparations for animals, namely antifungal, antimicrobial, and antibacterial medications

Goods & Services

(1) Dietary and nutritional pet treats, namely, edible pet treats

Goods & Services

(1) Dietary and nutritional supplements for animals containing omega fatty acids.

Abstract

Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.

IPC Classes  ?

• A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Goods & Services

Veterinary preparations, namely, sedatives, analgesics, and pre-anesthetics for surgical and non-surgical use

Goods & Services

Veterinary preparations, namely, antibiotics

Goods & Services

Veterinary preparations, namely, antibiotics

Goods & Services

Veterinary preparations, namely, antibiotics

Goods & Services

Dietary and nutritional supplements for animals

Goods & Services

Dietary and nutritional supplements for animals

Goods & Services

Otic preparations for animals

Goods & Services

Medicated dermatological preparations for animals

Goods & Services

Non-medicated skin care preparations for animals

Goods & Services

Dermatological preparations and otic preparations for animals

Goods & Services

Dermatological preparations and otic preparations for animals

Goods & Services

Otic preparations for animals

Goods & Services

Dermatological preparations and otic preparations for animals

Goods & Services

Medicated dermatological preparations and otic preparations for animals

Goods & Services

Veterinary preparations, namely, non-steroidal anti-inflammatories for enteral or parenteral administration

Goods & Services

(1) Dietary and nutritional omega-3 fatty acid supplements for animals, feed supplements for animals and omega-3 fatty acid food supplements for animals.

Goods & Services

(1) Topical dermatological preparations for the treatment of bacterial and fungal infections in animals

Goods & Services

Edible pet treats and chews; digestible teeth cleaning treats and chews for pets

Goods & Services

Dietary and nutritional supplements for animals, feed supplements for animals and food supplements for animals

Goods & Services

Topical dermatological preparations for the treatment of bacterial and fungal infections in animals

Goods & Services

Manufacturing services for others in the field of drug products in the animal health market Distributorship services in the field of drug products in the animal health market Research and development of drug products in the animal health market

Abstract

The present invention relates to a composition for the treatment of skin and ear infections in humans and animals such as dogs, cats and horses. In particular, the present invention relates to a topical composition comprising acetic acid, an antibacterial and/or an anti-fungal, and preferably also an anti-inflammatory. More specifically, the composition of the present invention is a bandage, bedding, clothing, conditioner, cream, drape, dressing, film, foam, gauze, gel, lotion, mousse, otic solution, pad, patch, serum, shampoo, solution, spray, or wipe for treatment or prevention of skin infections, wherein the composition comprises about 0.1-10% acetic acid, about 0.1-10% boric acid, about 0.01-20% azole, and optionally about 0.01-20% corticosteroid.

IPC Classes  ?

• A61K 33/22 - Boron compounds
• A61K 31/155 - Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2)
• A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
• A61K 31/4174 - Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
• A61K 31/4164 - 1,3-Diazoles
• A61K 31/19 - Carboxylic acids, e.g. valproic acid
• A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Goods & Services

Veterinary preparations, namely, topical antibiotic dermatological spray

Abstract

The present invention relates to a composition for the treatment of skin and ear infections in humans and animals such as dogs, cats and horses. In particular, the present invention relates to a topical composition comprising acetic acid, an antibacterial and/or an anti-fungal, and preferably also an anti-inflammatory. More specifically, the composition of the present invention is a bandage, bedding, clothing, conditioner, cream, drape, dressing, film, foam, gauze, gel, lotion, mousse, otic solution, pad, patch, serum, shampoo, solution, spray, or wipe for treatment or prevention of skin infections, wherein the composition comprises about 0.1-10% acetic acid, about 0.1-10% boric acid, about 0.01-20% azole, and optionally about 0.01-20% corticosteroid.

IPC Classes  ?

• A61K 33/22 - Boron compounds
• A61K 31/4164 - 1,3-Diazoles
• A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
• A61P 17/04 - Antipruritics
• A61P 31/10 - Antimycotics
• A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
• A61P 31/04 - Antibacterial agents

Goods & Services

veterinary preparations, namely, medicated shampoos, sprays, and ear flushes for the treatment of bacterial infections; medicated pre-moistened wipes

Goods & Services

PRE-MOISTENED MEDICATED TOWELETTES FOR PETS; MEDICATED PET SHAMPOO AND CONDITIONER; MEDICATED TOPICAL SPRAY FOR PETS FOR USE IN TREATING SKIN DISORDERS

Goods & Services

DENTIFRICE IN GEL OR PASTE FORM FOR HUMAN AND/OR VETERINARY USE

Goods & Services

petrolatum ophthalmic ointment